Gentamicin in neonates with hemodynamically significant patent ductus arteriosus

Gentamicin in neonates with hemodynamically significant patent ductus arteriosus

Background: Gentamicin has been shown to cause vasodilation in preclinical studies. Hemodynamically significant patent ductus arteriosus (hsPDA) is a commonly observed congenital heart disorder in preterm neonates. Concomitant gentamicin theoretically shall delay the closure/result in nonclosure of...

Full description

Bibliographic Details
Main Authors: Kannan Sridharan, Abdulraoof Al Madhoob, Muna Al Jufairi, Eman Al Ansari, Reem Al Marzooq, Zakariya Hubail, Sadiq Jaafar Hasan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Journal of Pharmacy and Bioallied Sciences
Subjects:
aminoglycosides
cardiovascular effects
gentamicin
pda
Online Access:http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2023;volume=15;issue=2;spage=95;epage=100;aulast=Sridharan

Internet

http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2023;volume=15;issue=2;spage=95;epage=100;aulast=Sridharan

Similar Items